Clinical Trials Logo

Recurrent Colorectal Cancer clinical trials

View clinical trials related to Recurrent Colorectal Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT04499586 Active, not recruiting - Clinical trials for Recurrent Colorectal Cancer

A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer

Start date: January 1, 2019
Phase: Phase 2
Study type: Interventional

The study evaluates the effectiveness of radiotherapy combined with raltitrexed and irinotecan in treating patients who have metastatic or locally recurrent colorectal cancer that has not responded to fluorouracil. The patients will receive radiotherapy combined with raltitrexed and irinotecan, and then the surgeons will evaluate whether they should receive a surgery.

NCT ID: NCT01862003 Completed - Clinical trials for Metastatic Colorectal Cancer

Phase I/II Trial of Antagonism of HER in GI Cancer

PANTHER
Start date: May 2014
Phase: Phase 2
Study type: Interventional

Recruitment to phase I of the PANTHER trial is complete. Phase II, is to evaluate the best overall response rate for AZD8931 + FOLFIRI treatment.